SBC Medical Posts Q4 EPS Doubling While Launching Performance Medicine Push Into $2 Trillion Longevity Market
SHERIDAN, WYOMING - April 14, 2026 - SBC Medical Group Holdings Incorporated (Nasdaq: SBC), an Irvine, California-based Management Services Organization, reported fourth-quarter earnings per share more than doubling to $0.14, marking a significant year-over-year improvement in profitability. The results, disclosed on March 27, arrived alongside the company's announcement of a full-scale entry into the longevity healthcare market through a newly defined "Performance Medicine" category. SBC Medical simultaneously disclosed the acceleration of its multi-branding strategy in aesthetic healthcare, including expansion into Tokyo's premier district. Together, the three announcements signal both financial recovery and a deliberate pivot toward higher-growth healthcare verticals.